Journal article
Erythropoiesis-stimulating agents (ESAs): Do they still have a role in chemotherapy-induced anemia (CIA)?
Abstract
PURPOSE: Anemia in cancer patients can be a result of the underlying cancer or related to treatment. Erythropoiesis-stimulating agents (ESAs) are an important option for many patients with chemotherapy-induced anemia, but are immersed in controversy. This article aims to reconcile conflicting opinions and provide expert guidance for appropriate ESA use.
METHODS: Teleconference, email, and a face-to-face meeting were used to assess ESA therapy …
Authors
Bormanis J; Quirt I; Chang J; Kouroukis CT; MacDonald D; Melosky B; Verma S; Couture F
Journal
Critical Reviews in Oncology/Hematology, Vol. 87, No. 2, pp. 132–139
Publisher
Elsevier
Publication Date
August 2013
DOI
10.1016/j.critrevonc.2012.12.010
ISSN
1040-8428